CT
Citius Oncology, Inc. (CTOR)
NASDAQ·Healthcare·Drug Manufacturers - General
$0.86
-1.67%
Mkt Cap $77.11M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 13, 2026 | $4.37M | $3.94M | -9.81% | -$0.04 | -$0.06 | -50.00% | — | — |
| Q4 2025 Dec 23, 2025 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.15 | -$0.08 | +46.67% | — | — |
| Q2 2025 May 14, 2025 | $5.74M | — | — | -$0.09 | -$0.11 | -22.22% | — | — |
| Q1 2025 Feb 14, 2025 | — | — | — | -$0.06 | -$0.09 | -50.00% | — | — |
| Q4 2024 Dec 27, 2024 | — | — | — | -$0.08 | -$0.07 | +10.33% | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | $0.01 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.05 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | $0.00 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | $0.07 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | $0.07 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | $0.04 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.00 | — | — | — |
| Q2 2021 Apr 30, 2021 | — | — | — | — | -$0.00 | — | — | — |